Dmitriy Zamarin, MD, PhD, has been awarded the 2026 Liz Tilberis Research Prize for Outstanding Early Career Investigators by Ovarian Cancer Research Alliance (OCRA).
A physician-scientist whose research has explored new approaches to harnessing the immune system against ovarian cancer, Dr. Zamarin is Professor of Oncology, Section Head of Gynecologic Medical Oncology, and Co-Director of the Center of Excellence for Gynecologic Cancers at the Tisch Cancer Center, Icahn School of Medicine at Mount Sinai.
“Early in my clinical career, I found it frustrating how little we could do to change outcomes for ovarian cancer patients in clinic,” said Dr. Zamarin. “That frustration became fascination once I dug into the biology: the disease turned out to be as scientifically compelling as it was clinically stubborn, and that combination has held my attention ever since.”
Advancing Immunotherapy Research for Ovarian Cancer
Initially funded by OCRA through the Liz Tilberis Early Career Award, his research has identified genetic changes inside ovarian cancer cells that determine how recognizable they are to the immune system and helped pioneer the use of engineered viruses that destroy cancer cells while triggering an immune response.
“Progress against ovarian cancer requires scientists willing to challenge assumptions and pursue entirely new approaches to treatment. Dr. Zamarin has done just that, advancing our understanding of the immune system and its potential to transform how we treat ovarian and other gynecologic cancers,” said Audra Moran, President and CEO of OCRA. “His work reflects the bold thinking and scientific innovation that will drive the next generation of breakthroughs.”
Recognizing Research Achievements in Memory of Liz Tilberis
Chosen by a panel of select members from OCRA’s Scientific Advisory Committee, Dr. Zamarin was honored with the Liz Tilberis Prize at the 16th Biennial Rivkin Ovarian Cancer Research Symposium in October.
This $5,000 biennial prize honors the legacy of Liz Tilberis, former editor-in-chief of Harper’s Bazaar and OCRA’s first president, who passed away from ovarian cancer in 1999. It is awarded to an individual who best demonstrates the use of prior OCRA funding to impact the field of ovarian cancer research. Only past recipients of OCRA’s Liz Tilberis Early Career Award/Early Career Investigator Grant qualify.